Great to have BTOG back in Belfast. A really great meeting. Well done to all

BTOG Niall McGonigle Mariana Brandao And here we are

Dr Sanjay Agrawal gives a superb overview of Interstitial Lung Disease (ILD) classification and treatment at #BTOG24 this afternoon.

Real need to develop more effective treatments of ILD

David Baldwin Congratulations on receiving the #BTOG24 lifetime achievement award.

David Baldwin congratulations Prof Baldwin - a well-deserved honour. Not only dedicated - but great to work with! Best wishes from all at #UKOF24 & Athena Meetings #BTOG24

Fantastic event and great to catch up with all the great #patientAdvocates here at #BTOG24 .

Just announced! Three meso charities.. Meaningful meso research 😃

BTOG #BTOG24 #mesocollective #mesothelioma #hasag #erasemeso #mavisnyefoundation

Positive start to #BTOG24 NLCA audit data shows 30% of people in England & Wales diagnosed at stage I & II. Important improvements to build on. Neal Navani

LungSpecialist presents National Lung Cancer Audit State of the Nation report

✅Increase in surgery
🔺Rates of SACT too low
🔺Waiting times too long
✅High access to lung CNS
✅48% 1yr survival, increasing
✅ No survival outliers

❗️Essential metrics
🫵 Download your Trust’s data

#BTOG24

Matt Callister: who should we invite for lung cancer screening?

🔹Yorkshire Lung Screening Trial
🔹Those most at risk also most likely not to attend
🔹88% stage I & II disease in incidence rounds
🔹Risk scores more efficient than risk factors

#LCSM #BTOG24

Day 3 @ #BTOG24 . Prof Baldwin highlights need to improve symptomatic diagnosis alongside roll out of Screening. Acceleration of Optimum pathway.

Our first time at BTOG #BTOG24 #Belfast . We have been blown away by the last few days. Fantastic speakers, great to see old faces and to meet new ones. Until next year... Thank you #Mesothelioma #lung

Robert Rintoul on a very specific, growing complication of lung cancer survivorship… Second, genomically distinct lung cancers. Data presented fits with our practice. I in 6 will develop a second primary within 4 years. Also makes me thankful for SABR BTOG #BTOG24

Robert Rintoul: Optimal follow up for lung cancer long term survivors

👉 To detect recurrence & 2nd primaries (SPLC)
👉 ⬆️ risk SPLC continues beyond 10yrs @ 3.4% pa
🤔 Risk stratified Manchester follow up?
👏SPORT study of SPLC ongoing

#BTOG24 #LCSM

Great talk from Robert Rintoul at #BTOG24 . Why do we follow patients up after #LungCancer treatment?
To diagnose recurrence?
But also to diagnose second primary cancers.
How long should we follow patients for? 5 years or longer?

What a fabulous #BTOG24 💜 - educational, inspirational, meaningful and fun! Plus, so great to hang out with our friends at UKALK+ and Ruth Strauss Foundation #LungCancer #EGFR

Pressure on CNS service = commonest reason why diagnostic ctDNA not undertaken

Important consideration when setting up this routine service

Great work fromSandra Wakelin and Dr Riyaz Shah

#BTOG24 #LCSM

#BTOG24 evolution of #mesothelioma in inflammatory pleuritis. 5% in all studies, 15% in high asbestos exposure studies. Clinically important topic. Highlights the importance of research networks in surveillance & prevention in this field 👏👏Kevin Blyth 💙 PREDICT-Meso

Just Out
U.S. FDA 🇺🇸 approves alectinib for adjuvant treatment following tumor resection in patients with ALK positive non-small cell lung cancer #NSCLC 🫁 Based on Results from ALINA

fda.gov/drugs/resource…

Christian Rolfo gilberto lopes Narjust Florez, MD, FASCO Stephen V Liu, MD H. Jack West, MD…